Janux Therapeutics News

Janux Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Dobek Maria

Aug 9 19:08 ET

Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(3.8%),OrbiMed Capital GP VIII LLC(3.4%), etc.

Aug 9 16:13 ET

Janux Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 7 22:24 ET

Janux Therapeutics | 8-K: Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

Aug 7 16:28 ET

Janux Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director DOBMEIER ERIC

Jul 24 20:05 ET

Janux Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Hernday Natasha

Jul 24 20:05 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DOBMEIER ERIC

Jul 22 20:07 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hernday Natasha

Jul 22 20:07 ET

Janux Therapeutics | 3: Initial statement of beneficial ownership of securities-Director DOBMEIER ERIC

Jul 22 20:02 ET

Janux Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Hernday Natasha

Jul 22 20:02 ET

Janux Therapeutics | 8-K: Current report

Jul 22 17:03 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

Jun 28 16:39 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CAPPS VICKIE L

Jun 28 16:34 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Simson Jake

Jun 28 16:34 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Barrett Ronald W

Jun 28 16:34 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gujrathi Sheila

Jun 28 16:34 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kung Winston

Jun 28 16:34 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director McNulty Alana B.

Jun 28 16:34 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lichter Jay

Jun 28 16:34 ET

Janux Therapeutics | 8-K: Current report

Jun 28 16:17 ET